CBLL

Ceribell Stock Analysis

AI Rating

Good
  • Quality0/10
  • Growth 6/10
  • Momentum 7/10
Ceribell sales and earnings growth
CBLL Growth
Good
  • Revenue Y/Y 37.93%
  • EPS Y/Y 107.93%
  • FCF Y/Y -23.34%
Ceribell gross and profit margin trends
CBLL Profitability
Neutral
  • Gross margin 88.00%
  • EPS margin -63.30%
  • ROIC -43.40%
Ceribell net debt vs free cash flow
CBLL Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -26.2

Ceribell stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗